Ship Healthcare Holdings, Inc.
Fiscal Year Ending March 2026 Q3 Financial Presentation Materials
For the cumulative Q3 period of the fiscal year ending March 2026, net sales were JPY 522,415 million, up 6.1% year-over-year (YoY); operating income was JPY 14,450 million, down 4.4% YoY; and net income attributable to owners of parent was JPY 9,381 million, down 10.8% YoY.
Key Figures
- Net Sales: JPY 522,415 million (Year-over-Year +6.1%)
- Operating Income: JPY 14,450 million (Year-over-Year -4.4%)
- Net Income Attributable to Owners of Parent: JPY 9,381 million (Year-over-Year -10.8%)
AI要約
Performance Overview
For the cumulative Q3 period of the fiscal year ending March 2026, net sales reached JPY 522,415 million (up 6.1% YoY), progressing as planned. Operating income was JPY 14,450 million (down 4.4% YoY), primarily impacted by the concentration of large projects in the second half and rising utility and labor costs. Ordinary income was JPY 15,462 million (down 6.5% YoY), and net income was JPY 9,381 million (down 10.8% YoY). Overall group progress aligns with initial plans, with operational efficiency gains from the PH business integration contributing positively to profits.
Segment Performance
Net sales by segment were as follows: Medical Supply Business (MSP) at JPY 378,475 million (up 7.5% YoY), Total Pack Produce Business (TPP) at JPY 89,898 million (up 3.0% YoY), Life Care Business (LC) at JPY 28,158 million (up 1.9% YoY), and Pharmacy Business (PH) at JPY 25,883 million (up 2.8% YoY). Operating income increased in MSP to JPY 4,758 million (up 13.1% YoY) and PH to JPY 3,078 million (up 20.9% YoY), while TPP declined to JPY 4,984 million (down 24.3% YoY) and LC decreased to JPY 1,707 million (down 2.3% YoY). The decrease in TPP operating income was due to the absence of completed large-scale projects, along with the impact of yen depreciation driving up procurement costs for radiotherapy equipment and the recording of one-time expenses.
